Clinical significance of weight loss in cancer patients: rationale for the use of anabolic agents in the treatment of cancer-related cachexia.
Langer
C J
CJ
Fox Chase Cancer Center, Philadelphia, Pa., USA.
Hoffman
J P
JP
Ottery
F D
FD
D045930:Anabolic Agents / Q000627:therapeutic use*; D019167:Appetite Stimulants / Q000627:therapeutic use; D001835:Body Weight; D002100:Cachexia / Q000188:drug therapy* / Q000378:metabolism / Q000628:therapy; D019247:HIV Wasting Syndrome / Q000188:drug therapy; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D015596:Nutrition Assessment; D009748:Nutrition Disorders / Q000150:complications* / Q000188:drug therapy; D009752:Nutritional Status; D018529:Nutritional Support; D010074:Oxandrolone / Q000627:therapeutic use*; D012449:Safety; D016019:Survival Analysis; D015431:Weight Loss
D045930:Anabolic Agents; D019167:Appetite Stimulants; D010074:Oxandrolone